The developing digital health sector has had to wait almost three years for the public markets to open up to it, but when they did, it was corporate venturing portfolio companies that were first through the flotation exit doors.

And the delay has perhaps been even more surprising with the performance of IRhythm Technologies, a Novo, St Jude and Kaiser Permanente-backed cardiac diagnostics technology developer┬áthat floated in October 2016 above its range at $17 per share and has continued to see a steady rise in value to $75 by mid-August this year and a…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.